Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroxine for IVH in Preterm Infants
NCT03390530Phase 3Withdrawn
- Sponsor
- Albert Einstein College of Medicine
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levothyroxine sodium in Intraventricular hemorrhage (IVH), sponsored by Albert Einstein College of Medicine. Planned start Jan 2022; status: withdrawn.
02
Drugs
levothyroxine sodium
03
Conditions
Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on NCT03390530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390530.